Literature DB >> 16360418

CD14 and CD169 expression in human lymph nodes and spleen: specific expansion of CD14+CD169- monocyte-derived cells in diffuse large B-cell lymphomas.

Béatrice Marmey1, Charlotte Boix, Jean-Baptiste Barbaroux, Marie-Caroline Dieu-Nosjean, Jacques Diebold, Josée Audouin, Wolf-Herman Fridman, Chris G F Mueller, Thierry J Molina.   

Abstract

The mononuclear phagocyte system of human lymphoid tissue comprises macrophages and dendritic cells (DCs). The heterogeneity of the non-DC mononuclear phagocyte population in human lymphoid tissue has been little addressed. Here, we studied the expression of 2 monocyte-derived markers, CD14 and CD169 (sialoadhesin), in reactive human lymphoid tissue as well as in a series of 51 B-cell lymphomas by immunohistochemistry on paraffin-embedded tissue. We confirmed that lymph node sinusoidal monocyte-derived cells were the only population staining for CD169. Although most sinusoidal histiocytes also expressed CD14, monocyte-derived cells with phagocytosis such as erythrophagocytosis, anthracosis, or tingible bodies macrophage lacked CD14 and CD169. Among B-cell lymphomas, splenic marginal zone lymphoma was the only one associated with an expansion of the CD14(+)CD169(+) cells in the cords. With respect to nodal B-cell lymphomas, CD14(+) cells were rare among B-chronic lymphocytic leukemia, follicular lymphoma (FL), mantle cell lymphoma (MCL). However, strikingly, we found a strong expansion of CD14(+)CD169(-) cells in numerous diffuse large B-cell lymphomas (DLBCLs), except in cases associated with numerous mitoses, apoptotic bodies, and tingible bodies macrophages. When cultivated in granulocyte/macrophage colony stimulating factor/interleukin 4, DLBCL purified CD14(+) cells differentiate into plasmacytoid cells, expressing DC-specific intercellular adhesion molecule 3-grabbing nonintegrin, suggesting dendritic cell differentiation potential. Our observation fits well with the lymph node and host response cluster signatures described in the gene profiling signatures of DLBCL. However, the role of this CD14(+) population that may constitute a microenvironment-related marker of this subgroup of DLBCL remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16360418     DOI: 10.1016/j.humpath.2005.09.016

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  17 in total

Review 1.  The host-tumor interface in B-cell non-Hodgkin lymphoma: a new world to investigate.

Authors:  Nicolas Rachinel; Gilles Salles
Journal:  Curr Hematol Malig Rep       Date:  2009-10       Impact factor: 3.952

2.  Distinctive localization of antigen-presenting cells in human lymph nodes.

Authors:  Catherine E Angel; Chun-Jen J Chen; Oliver C Horlacher; Sintia Winkler; Thomas John; Judy Browning; Duncan MacGregor; Jonathan Cebon; P Rod Dunbar
Journal:  Blood       Date:  2008-11-05       Impact factor: 22.113

3.  Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab era.

Authors:  Tamar Tadmor; Alessia Bari; Stefano Sacchi; Luigi Marcheselli; Eliana Valentina Liardo; Irit Avivi; Noam Benyamini; Dina Attias; Samantha Pozzi; Maria Christina Cox; Luca Baldini; Maura Brugiatelli; Massimo Federico; Aaron Polliack
Journal:  Haematologica       Date:  2013-08-09       Impact factor: 9.941

4.  Revisiting the immune microenvironment of diffuse large B-cell lymphoma using a tissue microarray and immunohistochemistry: robust semi-automated analysis reveals CD3 and FoxP3 as potential predictors of response to R-CHOP.

Authors:  Rita Coutinho; Andrew J Clear; Emanuele Mazzola; Andrew Owen; Paul Greaves; Andrew Wilson; Janet Matthews; Abigail Lee; Rute Alvarez; Maria Gomes da Silva; José Cabeçadas; Donna Neuberg; Maria Calaminici; John G Gribben
Journal:  Haematologica       Date:  2014-11-25       Impact factor: 9.941

5.  Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma.

Authors:  Yi Lin; Michael P Gustafson; Peggy A Bulur; Dennis A Gastineau; Thomas E Witzig; Allan B Dietz
Journal:  Blood       Date:  2010-11-09       Impact factor: 22.113

6.  The detection of CD14 and CD16 in paraffin-embedded bone marrow biopsies is useful for the diagnosis of chronic myelomonocytic leukemia.

Authors:  Marwan Qubaja; Béatrice Marmey; Agnès Le Tourneau; Stéphanie Haiat; Dominique Cazals-Hatem; Bettina Fabiani; Jacques Diebold; Jean-Pierre Marie; Josée Audouin; Frédéric Geissmann; Thierry Jo Molina
Journal:  Virchows Arch       Date:  2009-02-26       Impact factor: 4.064

Review 7.  Sialoadhesin - a macrophage-restricted marker of immunoregulation and inflammation.

Authors:  Alexander S G O'Neill; Timo K van den Berg; Gregory E D Mullen
Journal:  Immunology       Date:  2013-03       Impact factor: 7.397

8.  Influence of Tumor Location on the Composition of Immune Infiltrate and Its Impact on Patient Survival. Lessons from DCBCL and Animal Models.

Authors:  Claire Galand; Sabrina Donnou; Thierry Jo Molina; Wolf Herman Fridman; Sylvain Fisson; Catherine Sautès-Fridman
Journal:  Front Immunol       Date:  2012-05-04       Impact factor: 7.561

Review 9.  Altered tumor-cell glycosylation promotes metastasis.

Authors:  Irina Häuselmann; Lubor Borsig
Journal:  Front Oncol       Date:  2014-02-13       Impact factor: 6.244

10.  A Higher Frequency of CD14+ CD169+ Monocytes/Macrophages in Patients with Colorectal Cancer.

Authors:  Chenguang Li; Xiaofan Luo; Yuyang Lin; Xiuqi Tang; Limian Ling; Lei Wang; Yanfang Jiang
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.